Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.
about
The epidemiology of sarcomaSeroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, ChinaIdentification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirusIdentification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localizationThe 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigenThe viral etiology of AIDS-associated malignanciesRisk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control studyHistorical review of the causes of cancerThe Role of Gammaherpesviruses in Cancer PathogenesisThe conundrum of causality in tumor virology: the cases of KSHV and MCVMolecular Approaches to the Identification of Unculturable Infectious AgentsCapsid structure of Kaposi's sarcoma-associated herpesvirus, a gammaherpesvirus, compared to those of an alphaherpesvirus, herpes simplex virus type 1, and a betaherpesvirus, cytomegalovirusThe anti-interferon activity of conserved viral dUTPase ORF54 is essential for an effective MHV-68 infection.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cellsKSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.Signaling activities of gammaherpesvirus membrane proteinsTranscription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus.Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma.DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirusActivation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesisReactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latencyQuantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR.Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection.Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.Comparison of serologic assays for detection of antibodies against human herpesvirus 8.The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation.Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.Human herpesvirus 8 induces polyfunctional B lymphocytes that drive Kaposi's sarcomaCharacterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCRKaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse.Viruses and human cancer: from detection to causality.Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapyHHV8 and Kaposi's sarcoma: a time cohort study.Higher levels of neutralizing antibodies against KSHV in KS patients compared to asymptomatic individuals from Zambia.Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids.Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.
P2860
Q21195878-62BCA238-D61D-46ED-84CA-DEFE9EE2F960Q21245098-E9EF7928-3373-4FEE-8AEA-41A66E988C20Q24561400-A7681F6C-7D44-4558-8F1F-EB87DF436BA6Q24648127-EDFA2F6F-2FC6-4730-9900-0F633F0CC1A6Q24672438-529E4D34-C2D5-480F-98E7-473BD750B707Q24685892-DB57D752-87DA-4C3B-B91C-6DC0734CD41CQ24804288-9D434915-09ED-4568-AF1B-C58824644BBFQ26767036-3926A171-A707-4352-B347-E7FECF3DFB40Q26767186-9E39C66A-DE0C-4B56-9648-774C400DF987Q26863112-21C85F7C-224F-43B6-8740-9590A59C16BAQ27487576-EEC93327-E6C4-4A72-AF73-75835459FB3DQ30453457-F91A964D-228A-4A85-8544-9A69F278DE3BQ31036561-E0F20B64-A6FA-4D7C-8C80-11A4A10588D0Q33560572-747EEACE-79D7-4877-8AC0-9502CC79E717Q33647345-84C2E923-CFAD-466D-BEE7-5A6A1D667BB3Q33761091-18E5FA3A-168F-4B82-9AD7-A373E64BCC62Q33772234-9A8CE7B1-0B62-402D-89C9-DBD4C90A9D02Q33822504-D29CC5DB-630D-4699-853E-18FF44FB5E2BQ33837983-BE86A953-B9D7-4343-B6BC-AE1409B767D5Q33844645-EACA30E6-7381-4A7E-87CF-903E1CB9BD44Q33853499-195BB060-D800-4A15-9D0B-13F4D9205E4AQ33854532-362B8943-78E8-4AC5-837C-34CABD4C78F4Q33916507-CCF3A007-924D-4840-85A9-BFCBC2D1AB1AQ33967047-AF2E4C9E-C49B-464B-B086-E91E6B3797A1Q33967384-358A2FC8-99BA-4561-8B3F-AFA7D358C84EQ33974199-FDFD45AB-813E-4288-B1B8-76FC21A012A3Q33999426-62D8F2F2-C3BA-48C6-A5F6-82C1CE1B9A40Q34130213-87FA6725-95BF-4856-9A3F-8D1481618188Q34168712-EE4646FA-2B50-42BB-B2D6-C97D8B9B5C84Q34237804-99422B1C-BEE9-4666-939C-D4D272985550Q34338900-D5D37E8D-F55C-4172-B91E-9435232A8F21Q34340317-B1BCE94D-A364-4AD9-862F-FCE8F47FED5BQ34471059-6FA00FA7-1453-4880-8C0A-6840A226F133Q34567612-679DEAF7-4B4C-42DB-A60E-B2F9FE729FCAQ34587349-76C61C96-6E61-4E55-B3A1-CB7C01E73A5DQ34635757-D8A35D47-ED5C-4762-A8AA-33F57636E04EQ34741956-EF44BD8E-E4E5-49E0-BFB1-E129782F264AQ34963626-BEAD8977-5F64-4403-AA63-69300D29FD20Q34988603-37053A0A-B0BF-4DE3-8055-EBBBEA148711Q35026060-DDB37181-F232-400C-98D4-811F7F3E7586
P2860
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.
@ast
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.
@en
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.
@nl
type
label
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.
@ast
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.
@en
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.
@nl
prefLabel
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.
@ast
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.
@en
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.
@nl
P2093
P1433
P1476
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma.
@en
P2093
Holmberg SD
Kingsley LA
P304
P407
P577
1996-02-01T00:00:00Z